Among active 13F managers last quarter, 4 opened and 29 added, while 17 reduced; the largest holder to move was Janus Henderson Group Ltd. (12× the prior stake). No open-market insider trades in the last 180 days.
Funds lean in and no leg opposes.
263 tracked 13F filers disclose a position in BHVN as of the latest SEC 13F filings, a combined $1.7B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Janus Henderson Group Ltd. | 17.5M | $148.2M | ▲12× Added · +16.1M sh | Q1 2026 | |
| 2 | BlackRock, Inc. | 13.2M | $196.6M | ▲+18% Added · +2.0M sh | Q2 2026 | |
| 3 | Montanova Capital, LLC | 10.3M | $153.1M | —Held | Q2 2026 | |
| 4 | Stifel Financial Corp | 9.9M | $84.1M | ▲~0% Added · +1K sh | Q1 2026 | |
| 5 | Woodline Partners LP | 7.7M | $114.0M | ▲26× Added · +7.4M sh | Q2 2026 | |
| 6 | State Street Corp | 6.9M | $103.4M | ▲+5.0% Added · +328K sh | Q2 2026 | |
| 7 | Infinitum Asset Management, LLC | 6.3M | $93.0M | —Held | Q2 2026 | |
| 8 | Geode Capital Management, LLC | 3.3M | $49.5M | ▲+20% Added · +555K sh | Q2 2026 | |
| 9 | FMR LLC | 3.0M | $44.1M | ▲+26% Added · +606K sh | Q2 2026 | |
| 10 | Royalty Pharma Sub-Manager, LLC | 2.9M | $43.7M | —Held | Q2 2026 | |
| 11 | D. E. Shaw & Co., Inc. | 2.8M | $24.1M | ▲+5.7% Added · +153K sh | Q1 2026 | |
| 12 | Cormorant Asset Management, LP | 2.6M | $38.8M | ▲+48% Added · +850K sh | Q2 2026 | |
| 13 | Goldman Sachs Group Inc | 2.5M | $21.3M | ▲+28% Added · +551K sh | Q1 2026 | |
| 14 | Vanguard Portfolio Management LLC | 2.5M | $37.0M | ▲+9.2% Added · +210K sh | Q2 2026 | |
| 15 | Balyasny Asset Management L.P. | 2.4M | $20.7M | ▲+54% Added · +854K sh | Q1 2026 | |
| 16 | AQR Capital Management LLC | 2.0M | $16.7M | ▲+35% Added · +515K sh | Q1 2026 | |
| 17 | TCG Crossover Management, LLC | 1.8M | $26.5M | ▼−62% Reduced · −2.9M sh | Q2 2026 | |
| 18 | Rubric Capital Management LP | 1.7M | $25.6M | ▲New +1.7M sh | Q2 2026 | |
| 19 | Citadel Advisors LLC | 1.6M | $24.1M | ▼−6.0% Reduced · −103K sh | Q2 2026 | |
| 20 | BNP Paribas Financial Markets | 1.5M | $13.1M | ▼−26% Reduced · −549K sh | Q1 2026 | |
| 21 | Qube Research & Technologies Ltd | 1.5M | $13.0M | ▼−1.9% Reduced · −30K sh | Q1 2026 | |
| 22 | Adage Capital Partners GP, L.L.C. | 1.5M | $12.7M | ▲+899% Added · +1.3M sh | Q1 2026 | |
| 23 | Vanguard Capital Management LLC | 1.5M | $22.2M | ▲+17% Added · +219K sh | Q2 2026 | |
| 24 | Price T Rowe Associates Inc | 1.5M | $21.7M | ▼−34% Reduced · −760K sh | Q2 2026 | |
| 25 | Millennium Management LLC | 1.4M | $12.2M | ▲+9.3% Added · +124K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 4 funds opened a new position in BHVN and 29 added to an existing one, while 17 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Amazon.com IncAMZN | 145 funds | $147.2B |
| Nvidia CorpNVDA | 141 funds | $304.5B |
| Microsoft CorpMSFT | 141 funds | $188.3B |
| Meta Platforms Inc-Class AMETA | 140 funds | $83.2B |
| Eli Lilly & CoLLY | 140 funds | $65.8B |
| Alphabet Inc-CL AGOOGL | 137 funds | $129.0B |
| Apple IncAAPL | 136 funds | $219.7B |
| Micron Technology IncMU | 136 funds | $44.3B |
| Advanced Micro DevicesAMD | 136 funds | $44.2B |
| Lam Research CorpLRCX | 135 funds | $34.6B |
| Broadcom IncAVGO | 134 funds | $123.4B |
| Chevron CorpCVX | 132 funds | $22.1B |
Ranked by how many of BHVN's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in BHVN.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Nov 17, 2025 | Clark George C. | VP, Chief Accounting Officer | Buy (P) | 17K | $145K |
| Nov 13, 2025 | Coric Vlad | Chief Executive Officer, Director | Buy (P) 2 lots, same day | 667K | $5.0M |
| Nov 13, 2025 | Childs John W | Director | Buy (P) | 3.3M | $25.0M |
| Nov 13, 2025 | Bailey Gregory | Director | Buy (P) | 400K | $3.0M |
| Mar 4, 2025 | Childs John W | Director | Buy (P) | 28K | $864K |
| Dec 30, 2024 | Childs John W | Director | Buy (P) | 29K | $1.0M |
| Oct 2, 2024 | Coric Vlad | Chief Executive Officer, Director | Buy (P) | 21K | $1000K |
| Oct 2, 2024 | Childs John W | Director | Buy (P) | 21K | $1000K |
| Sep 24, 2024 | Bailey Gregory | Director | Buy (P) | 5K | $221K |
| Jul 18, 2024 | Childs John W | Director | Buy (P) | 28K | $1.0M |
| Jun 17, 2024 | Car Bruce | Chief Scientific Officer | Buy (P) | 30K | $1.0M |
| May 30, 2024 | Childs John W | Director | Buy (P) | 28K | $996K |
One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 61 | 28 | – |
Insiders Form 4 open-market | 0 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for BHVN
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/BHVN/capital-change-brief"
Use Arkolith's capital_change_brief for BHVN. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for BHVN. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.